Trombosis focal de vena femoral comúnmanifestación (jjVmssMark inicial de linfoma no Hodgkin difuso de células grandes B

  1. Ruth Fuente 1
  2. Diana Gutiérrez 1
  3. Miguel Martín Pedrosa 1
  4. Cintia Flota 1
  5. Carlos Vaquero 1
  1. 1 Hospital Universitario de Valladolid
    info

    Hospital Universitario de Valladolid

    Valladolid, España

    ROR https://ror.org/04fffmj41

Journal:
Revista Colombiana de Cancerología

ISSN: 2346-0199,  0123-9015

Year of publication: 2018

Volume: 22

Issue: 1

Pages: 53-56

Type: Article

DOI: 10.1016/J.RCCAN.2017.05.003 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Colombiana de Cancerología

Abstract

Abstract Deep venous thrombosis (DVT) is a common disease that annually affects 0.1-0.3% of the general population; It is also a significant cause of morbidity and mortality in cancer patients. DVT occurs more frequently in the treatment phase in which they are associated with the neoplastic prothrombotic process and effects of chemotherapy. In a small number of cases it is identified in the diagnosis or it may even be its first symptom. A secondary focal DVT extrinsic compression and destruction of surrounding tissue raises the suspicion of a malignant process. A case is presented of a focal DVT that was the first manifestation a non-Hodgkin's diffuse large B-cell lymphoma.

Bibliographic References

  • Swerdlow, SH,Campo, E,Harris, NL,Jaffe, ES,Pileri, SA,Stein, H. (2008). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press. Lyon, France.
  • Sant, M,Allemani, C,Tereanu, C,De Angelis, R,Capocaccia, R,Visser, O. (2010). Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 3724
  • Hui, D,Proctor, B,Donaldson, J,Shenkier, T,Hoskins, P,Klasa, R. (2010). Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Lymphoma. 1658
  • Armitage, JO,Weisenburger, DD. (1998). New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 2780
  • Falanga, A,Donati, MB. (2001). Pathogenesis of thrombosis in patients with malignancy. Int J Hematol. 137
  • Korte, W. (2008). Cancer and thrombosis: an increasingly important association. Support Care Cancer. 223
  • Caruso, V,Iacoviello, L,Di Castelnuovo, A,Storti, S,Mariani, G,de Gaetano, G. (2006). Thrombotic complications in childhood acute lym-phoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 paediatric patients. Blood. 2216
  • Caruso, V,Iacoviello, L,Di Castelnuovo, A,Storti, S,Donati, MB. (2007). Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis.. J Thromb Haemost. 621-6213
  • Kwaan, HC,Vicuna, B. (2007). Incidence and pathogenesis of thrombosis in hematologic malignancies. Semin Thromb Hemost. 303
  • Caruso, V,Di Castelnuovo, A,Meschengieser, S,Lazzari, M,de Gaetano, G,Storti, S. (2010). Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18018 patients and 1149 events.. Blood. 5322
Data source: Dialnet